Bill > SB443

This bill revises Montana's drug laws to significantly reduce THC (tetrahydrocannabinol, the primary psychoactive component in cannabis) concentrations across various marijuana products. The proposed changes would limit the total THC concentration in any marijuana or marijuana-derived product to 15%, which includes all forms such as flower, concentrates, tinctures, edibles, capsules, and transdermal patches. The bill aims to address what it describes as the harmful effects of high-potency THC, particularly on children, citing increased risks of addiction, psychotic episodes, schizophrenia, depression, and anxiety. The legislation maintains separate regulations for adult-use and medical marijuana dispensaries, with medical marijuana dispensaries still able to sell products with higher THC levels to registered cardholders. The bill reduces the maximum THC concentration in marijuana flower from 35% to 15% and maintains specific THC limits for different product types, such as 100 milligrams of THC per capsule and 10 milligrams per edible serving. The bill's preamble emphasizes protecting Montanans' health and liberty, particularly focusing on preventing addiction and protecting children from the potential negative impacts of high-potency THC products.

Business and Industry

https://bills.legmt.gov/#/laws/bill/2/LC2879